Myofascial Pain: An Evidence-Informed Guide for the Practicing Clinician

FRS–AAPM Myofascial Pain Guideline

Project Overview 

Myofascial pain is one of the most common pain presentations encountered in rehabilitation medicine, pain medicine, primary care, sports medicine, manual therapy, and allied health practice. Despite its clinical prevalence, terminology and diagnostic criteria remain inconsistent across disciplines. Clinicians may use overlapping terms such as myofascial pain syndrome, trigger point pain, regional soft-tissue pain, fascial pain, or muscle pain without a shared framework for diagnosis, mechanism, or treatment selection.

The Fascia Research Society is collaborating with the American Academy of Pain Medicine on a joint guideline-writing project to evaluate the current evidence regarding the diagnosis and management of myofascial pain. The goal is to produce practical, evidence-informed guidance for clinicians while also identifying areas where the evidence remains incomplete and further research is needed.

This project will bring together a multidisciplinary expert panel with representation from pain medicine, physical medicine and rehabilitation, anatomy, fascia research, rehabilitation science, manual therapy, interventional procedures, and related clinical disciplines. The final guideline is intended to support clinicians, researchers, educators, and patients by creating a clearer and more consistent framework for understanding and treating myofascial pain.

Objective

The objective of this guideline project is provide practical, evidence-informed recommendations for clinicians treating patients with myofascial pain.

The project seeks to clarify how myofascial pain is currently defined, how it is clinically identified, how it should be differentiated from other pain conditions, and how commonly used treatments should be evaluated in light of available evidence, safety, feasibility, and patient-centered outcomes.

Methods

An expert multidisciplinary panel will perform a structured review of the literature addressing the definition, clinical features, diagnostic evaluation, and treatment of myofascial pain. The review will include literature related to physical examination findings, fascial and muscular contributions to pain, differential diagnosis, and the clinical reasoning used to distinguish myofascial pain from neuropathic, radicular, and centralized pain presentations.

Therapeutic approaches under review will include exercise and rehabilitation, physical modalities, manual therapy, dry needling, injections, pharmacologic therapies, ultrasound-guided and interventional approaches where relevant, and multimodal interdisciplinary care. The panel will evaluate not only whether a treatment has supportive evidence, but also the clinical context in which it may be appropriate, the quality and limitations of the evidence, safety considerations, feasibility of implementation, and patient-centered factors such as function, disability, pain interference, and access to care.

Recommendations will be developed through a formal consensus process. Panel agreement will be measured for each recommendation statement. The strength of each recommendation will be informed by the quality of evidence, clinical applicability, safety, feasibility, and relevance to real-world clinical practice.

What This Project Aims to Accomplish

This project is designed to address several persistent problems in the clinical and scientific literature on myofascial pain.

First, the guideline aims to improve definitional clarity. Myofascial pain is widely discussed, but the field lacks consistent terminology across specialties. A central goal is to create a clinically usable framework that can be understood across pain medicine, rehabilitation, anatomy, physical therapy, manual therapy, and related disciplines.

Second, the project aims to improve diagnostic consistency. The literature includes variable descriptions of trigger points, taut bands, referred pain, local tenderness, movement restriction, and soft-tissue dysfunction. The guideline will evaluate which clinical features are best supported by the available evidence and how clinicians should interpret these findings in practice.

Third, the project aims to assess treatment options in a balanced and evidence-informed manner. Many interventions are used in clinical practice, but the quality of supporting evidence varies substantially. The guideline will help clinicians understand where evidence is stronger, where it is limited, and where recommendations must rely on expert consensus because high-quality trials are lacking.

Fourth, the project aims to identify research gaps. A major expected outcome is not only a set of clinical recommendations, but also a clearer map of what the field still needs: better definitions, improved diagnostic studies, mechanistic research, comparative-effectiveness trials, standardized outcome measures, and more rigorous evaluation of multimodal care.

Finally, the project aims to support interdisciplinary communication. Myofascial pain is not owned by a single specialty. A shared guideline can help reduce fragmentation and improve collaboration among clinicians, researchers, educators, and professional societies.

Anticipated Outputs

The project is expected to produce a formal guideline manuscript suitable for peer-reviewed publication. Additional outputs may include educational summaries, clinical tools, terminology tables, recommendation statements, and research-gap summaries that can be used by clinicians, trainees, researchers, and professional organizations.

The final recommendations are pending completion of the evidence review and consensus process.

Sponsorship Opportunities

FRS is seeking sponsorship support for this joint guideline-writing initiative. Sponsorship will help support the logistical, administrative, and scholarly work required to complete a rigorous multidisciplinary guideline process. This may include coordination of expert panel meetings, evidence review support, consensus methodology, manuscript preparation, administrative infrastructure, and dissemination of the final guideline.

Sponsorship does not determine the content of the guideline, influence the recommendations, or confer control over the evidence review, voting process, authorship, conclusions, or publication decisions. The guideline process will remain academically independent, evidence-informed, and governed by the participating expert panel and society-level oversight.

Sponsors will be acknowledged according to FRS policies and applicable publication standards. Depending on the sponsorship level and society policies, recognition may include acknowledgement on the FRS website, event or webinar recognition, inclusion in appropriate project communications, or acknowledgement in dissemination materials. Sponsor recognition will be clearly separated from guideline content and will not imply endorsement of any specific product, device, treatment, company, or commercial claim.

This project offers sponsors an opportunity to support an important interdisciplinary effort to improve the diagnosis, treatment, and scientific understanding of myofascial pain. The project is particularly relevant for organizations interested in pain medicine, rehabilitation, musculoskeletal care, fascia research, ultrasound-guided procedures, regenerative medicine, rehabilitation technology, medical education, and evidence-based clinical practice.

Abstract

Objective

To evaluate the available evidence regarding the diagnosis and management of myofascial pain and to provide practical, evidence-informed guidance for clinicians treating myofascial pain.

Methods

An expert multidisciplinary panel will perform a structured review of the literature addressing the definition, clinical features, diagnostic evaluation, and treatment of myofascial pain. Evidence will be reviewed for physical examination findings, trigger point–based assessment, differential diagnosis, and commonly used therapeutic approaches, including exercise and rehabilitation, manual therapy, dry needling, trigger point injections, pharmacologic therapies, and multimodal interdisciplinary care.

Recommendations will be developed through a formal consensus process, with panel agreement measured for each statement. The strength of recommendations will be informed by the quality of evidence, clinical applicability, safety, feasibility, and patient-centered considerations.

Results

Pending completion of the evidence review and consensus process.

Conclusions

Pending completion of the evidence review and consensus process. The anticipated guideline will provide practical recommendations for clinicians, clarify terminology and diagnostic considerations, summarize the current evidence for common treatment approaches, and identify priority areas for future research in myofascial pain.